Lapatinib
ALDRICH/CDS022971
CAS Number: 231277-92-2
Empirical Formula (Hill Notation): C29H26ClFN4O4S
Molecular Weight: 581.06
MDL Number: MFCD09264194
Linear Formula: C29H26ClFN4O4S
Product Type: Chemical
| description | AldrichCPR |
| form | solid |
| InChI | 1S/C29H26ClFN4O4S/c1-40(3 |
| InChI key | BCFGMOOMADDAQU-UHFFFAOYSA |
| SMILES string | CS(=O)(CCNCC1=CC=C(C2=CC= |
| General description: | Lapatinib is a tyrosine kinase inhibitor, targeting both the epidermal growth factor receptors, ErbB1 and ErbB-2. In combination with trastuzumab, it is reported to show complementary mechanisms of action and synergistic antitumor activity in breast cancer. |
| Other Notes: | Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final. NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY, (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE, OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY, WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H319 - H362 - H413 |
| Precautionary statements | P201 - P260 - P263 - P273 - P305 + P351 + P338 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |

